|
HS Code |
289481 |
| Chemical Name | 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester |
| Cas Number | 881898-18-6 |
| Molecular Formula | C6H7BrN2O2 |
| Molecular Weight | 219.04 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥ 95% |
| Solubility | Soluble in common organic solvents (e.g., DMSO, methanol) |
| Boiling Point | Decomposes before boiling |
| Smiles | COC(=O)c1[nH]c(nc1Br)C |
| Inchi | InChI=1S/C6H7BrN2O2/c1-9-3-4(5(10)11-2)8-6(9)7/h3H,1-2H3,(H,10,11) |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
As an accredited 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Anyone who's spent time in a chemical lab knows that finding reliable reagents can turn into a hunt for consistency. With 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester, research chemists get a tool that does more than just meet expectations––it feels familiar, but difference lies in the details. This molecule stands out for its balanced substitution on the imidazole core; that bromo group grabs attention for more than just its role as an electrophile. In my own work synthesizing heterocycles, compounds with tailored functional groups like this one regularly cut down reaction steps and let reactions proceed with better overall yields. Fewer steps often make life easier, especially when time and grant money are in short supply.
Think about the process: rigorous synthetic programs rely on predictable intermediates. Most labs don't have room for slowdowns caused by impure or stubborn reagents. The methyl ester on this imidazole offers a handle for further modification, so if your pathway involves hydrolysis, transesterification, or nucleophilic substitution, this compound gives clear options. There’s a practical logic to choosing molecular building blocks that ensure the fewest surprise byproducts. Everyone who's had to explain a failed reaction to a supervisor knows the value of clean, reliable inputs. This is one of those chemicals that fits well into stepwise synthesis, particularly where tight control over substitution patterns is required.
Not every brominated imidazole serves in such a flexible way. The addition of the methyl group on the nitrogen site, for instance, blocks unwanted side reactions. In one project building drug-like fragments for an early-stage patent, using the unmethylated analog led to consistent N-alkylation side products, which only became clear after two days of column chromatography. Reagents that force you to spend your afternoons hunched over silica gel are hard to justify now that compounds like this are easier to source. The distinction seems small until time and budgets start shrinking—then every hour and every milligram saved end up on your end-of-year report.
A lot of chemical write-ups are heavy with numbers and boiling points. There's no substitute for on-the-ground results, though. Researchers focusing on the development of kinase inhibitors, for instance, often look for imidazole frameworks because of their natural fit with biological targets. I’ve seen 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester serve as a central node in microwave-assisted couplings—something that was once a guessing game now plays out with the focus on optimizing just a few reaction parameters. That means fewer repeats on late nights for exhausted grad students, and cleaner separation between success and setback.
In medicinal chemistry, distinct functional groups matter more than anyone lets on outside the discipline. Bromo-substituted heterocycles often serve as key intermediates for Suzuki–Miyaura or Buchwald–Hartwig cross-coupling reactions. The predictable reactivity of this esterified bromo-imidazole shaves precious hours off project timelines. Each chemist remembers the awkward compounds that refuse to react, fouling up glassware and clogging up the workflow. Compared to standard 1H-imidazole derivatives, this one produces cleaner, more reproducible outcomes thanks to its selectivity and physical properties—especially during scale-up, when every inconsistency gets magnified.
The conversations around chemical supplies usually boil down to quality and reliability rather than abstract characterization. With a molecular formula of C6H6BrN2O2 and a molecular weight of about 233.03 g/mol, this compound strikes a balance between sufficient molecular complexity and practical purification. It fluoresces under certain wavelengths—an aspect that's occasionally helpful for tracking by TLC when hunting for elusive products among reaction mixtures. In my own workflows, this fluorescence once saved a batch from being poured down the drain by allowing a quick check with UV on a Friday afternoon.
Solubility keeps things practical in the lab. The methyl ester’s presence helps maintain moderate solubility in common organic solvents—DCM, methanol, ethyl acetate—without introducing stubborn emulsions during extractions. Compared with bulkier esterified imidazoles, it tends to crystallize cleanly, which turns purification by recrystallization into a realistic step instead of a futile experiment in patience. Analytical staff appreciate the sharp, characteristic NMR and mass spec signatures that make purity checks straightforward. Even small differences in these baseline properties add up through weeks of continuous lab work.
Synthesis in drug discovery, advanced agrochemical research, and library construction all benefit from the versatility of substituted imidazoles. In library synthesis protocols, 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester acts as a robust entry point for directed functionalization. A real advantage comes when working through multiple parallel reactions—having a reliable methyl ester group allows selective hydrolysis at a late stage, sparing the rest of the molecule from unwanted transformation. This versatility saves both time at the bench and money at the order desk.
Cross-coupling is more than a buzzword. The steady reactivity of the bromo group on position 4 of the imidazole ring links this compound to a wide array of aryl or vinyl partners—opening up exploration of new chemical space without reaching for new core scaffolds. This means students and senior investigators don’t lose momentum switching between different synthetic plans. I’ve watched trusted precursors like this keep synthetic campaigns on track even after biological results demand pivoting from one side chain to another.
Custom synthesis groups—where every client and project change direction midstream—rely heavily on flexibility in their intermediates. Having starting points that take well to downstream modifications pays off every time. For instance, the methylated nitrogen reduces potential for tautomerization, letting this compound serve as a stable placeholder for advanced, late-stage elaboration. This saves precious re-optimization cycles and sidesteps headaches where imidazole instability would otherwise mean lost batches and missed deadlines.
Traditional imidazole derivatives often force project teams to choose between high reactivity and manageable purification. In practice, 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester delivers both, supporting a smoother synthetic route without frequent detours for troubleshooting or resorting to brute-force purification schemes. Instead, workflow bottlenecks get cleared out, and the focus stays on innovation rather than recurring technical obstacles.
In real-world chemistry, not all analogues are equal. Subtle differences in substitution create huge changes in reactivity. Compared to the parent 1H-imidazole or 4-bromoimidazole, 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester resists unwanted polymerization during storage, maintaining consistent performance between orders. Less stability means wasted time repeating failed reactions, or multiple LC/MS runs to track down impurities that weren’t there last month. With this methyl ester, storage is less nerve-wracking even in less-than-ideal humidity.
Some teams rely on non-esterified carboxylic acids for their imidazole intermediates. The ester version, on the other hand, preserves the group for later-stage modifications—ideal for modular synthesis. On a recent collaboration, this flexibility let our group decide at the last moment whether to keep the ester or move to the acid. Working with non-ester versions leaves fewer options at the end game, often forcing earlier, less strategic choices about protecting groups and partner fragments.
The presence of the methyl group on the nitrogen delivers a clear advantage: methylation offers steric and electronic effects that control the reaction environment. For anyone who's lost a synthetic batch to unexpected side reactions on free imidazole, the methyl version brings reliability and fewer headaches. Standard 1H-imidazole derivatives too often become the root cause of unexpected byproducts, dragging down project morale and draining resources. In comparison, this compound’s substitution pattern turns it into a workhorse, not a liability.
Challenges in reproducibility and time-to-delivery haunt every research operation. Having access to consistent, high-purity intermediates lets synthetic chemists spend less energy fighting fires and more time pushing boundaries. 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester covers those bases. In crowded labs—whether at academic institutions, CROs, or industrial R&D facilities—simplifying purification workflows takes genuine pressure off teams. Every minute saved in workup turns into progress, either in terms of new data or hard-won publications.
A familiar frustration comes from switching suppliers or using inconsistent lots. I remember one week wasted on batch-to-batch differences with a cheaper source, only to discover that our key intermediate had degraded in storage. Reliability on such key intermediates prevents not just financial loss, but also burnout among researchers pushing hard to reach quarterly targets. Single-batch consistency means teams can plan more confidently and hand over projects without worrying about missed handoffs or surprise discontinuities in chemical behavior.
Building strong communication lines with reputable chemical providers helps, but teams should also keep clear internal records detailing minor handling differences—whether it's a change in storage temperature or just a longer exposure to room humidity. The minor variations in performance among substituted imidazoles often have cumulative effects as research timelines stretch out. Libraries and automated synthesis suites especially benefit from stable, well-characterized compounds that behave the same on every run, across multiple different projects.
Transparency in characterization and batch history makes a visible difference in how research teams work. Documenting and sharing analytical data—NMR, purity percentages, spectral features—lets users verify quality immediately, avoiding unnecessary reruns. In my view, modern practice in synthetic chemistry moves forward fastest when information is as available as the physical sample itself. This also helps satisfy both regulatory standards and the expectations of peer reviewers and journal editors, making eventual publication and patenting less stressful.
Every chemical brings questions about environmental impact and safety. Practical experience shows that well-designed molecules, with limited unnecessary features, create less chemical waste. Building new compounds using standard imidazole cores with functional handles—like methyl esters and bromo substituents—lowers the chemical footprint compared to more convoluted synthetic scaffolds. Simple, modular intermediates keep inventories manageable, which steers research away from overcomplicated or poorly scalable alternatives.
On the safety front, using methyl esters instead of free acids or highly reactive intermediates can often reduce hazardous exposure on the bench. I’ve noticed this difference first-hand—fewer corrosive vapors, lower skin irritation, and safer overall handling, especially for newer researchers getting comfortable on the hood. By sticking with intermediates like 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester, teams put themselves in a better position for a safe, predictable laboratory environment—something that’s hard to appreciate until an incident makes it glaringly obvious.
Storing and disposing of chemicals always hangs over lab operations. Esters like this one produce byproducts and waste streams that are easy to neutralize and dispose of using standard procedures. Simpler, more inert structures typically lower the risk of unexpected reactions both in storage and after use, and they make working with regulatory and environmental departments more straightforward. As the pressure increases for greener, more sustainable research operations, these practical compounds score points both in compliance and day-to-day management.
Trustworthiness in chemical supply, and the literature surrounding it, sits at the core of scientific credibility. Having direct experience with a product like 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester produces a different kind of trust than glowing product sheets or abstract claims. Teams trying to push knowledge forward want evidence of hands-on results, transparent sourcing, and consistent documentation. This makes the compound easier to recommend to colleagues, include in protocols, and cite in published work.
Expertise grows out of repeated, reproducible experience. In my time supervising synthesis projects, only certain building blocks passed repeated scrutiny without surprises cropping up batch after batch. Each new project that successfully moves forward using reliable intermediates like this one raises the bar for what researchers expect. Eventually, these habits of practical, clear science translate into better training for students, less waste, and more robust innovations on both small and large scales. The evidence supporting 4-Bromo-1-Methyl-1H-Imidazol-2-Carboxylic Acid Methyl Ester comes through in its widespread use and in the way experienced chemists come back to it time after time.
By focusing on chemical tools with proven track records, strong documentation, and known safety habits, the field of synthetic chemistry continues to make room for both innovation and accountability. The lessons learned from using specific, reliable intermediates like this one ripple across projects, making it easier for future teams to succeed without reinventing every wheel. Every workflow that depends on solid, thoughtfully designed molecules creates a direct line from the fundamentals of bench chemistry to the realization of complex, real-world goals.